Tudor Investment Corp
SGTX

Tudor Investment Corp’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Tudor Investment Corp’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-592
Closed -$370K – 1908
2020
Q4 		$370K Buy
+592
New +$370K 0.01% 1040